Tissue-engineered Skin Graft Repair of Autologous Scar Dermal Scaffolds

  • STATUS
    Recruiting
  • End date
    Dec 31, 2027
  • participants needed
    226
  • sponsor
    First Affiliated Hospital, Sun Yat-Sen University
Updated on 19 February 2024
deficiency
treatment guidelines
hypertrophy
adverse reactions
scar
skin damage
hypertrophic scar

Summary

Hypertrophic scar is an inevitable outcome of wound repair. It affects the appearance and some scar contracture often leads to joint dysfunction.Patients have low quality of life, long treatment cycle, heavy social burden and high medical costs.Skin grafting is currently the gold standard for scar repair.However, there are often insufficient skin sources, easy to scar recurrence, lack of skin accessory organs.The application of composite skin graft can reduce the recurrence rate of scar healing and relieve the deficiency of skin source.However, its survival rate is not high, and acellular allogeneic dermal scaffolds are expensive, heavy medical burden.Therefore, how to effectively repair the wound surface after surgical excision of scar is the main problem to be solved urgently.

Dermal loss is the main cause of unsatisfactory scar repair and recurrence.The previous clinical study of the research group found that the application of autologous epidermal basal cells and autologous skin graft obtained in real time during the operation could effectively improve the survival rate of skin graft in the treatment of wound surface (Brit J Surg, 2015).Furthermore, it is suggested that the application of autologous scar dermal scaffolds can achieve the control of skin damage in the skin harvesting area and the orthotopic transplantation of autologous scar tissue dermal scaffolds, which can effectively reduce the economic burden of patients.Therefore, the researchers wondered whether the construction of tissue-engineered skin orthotopic transplantation with autologous epidermal basal cells and autologous scar dermal scaffold combined with autologous scar dermal scaffolds to repair the wound after scar resection could improve the survival rate of skin graft and reduce scar recurrence.To this end, we plan to carry out multi-center, prospective, randomized, controlled clinical trials, aiming at proposing more effective surgical treatment guidelines for the repair of hypertrophic scar, improving the survival rate of composite skin graft, and solving the current clinical problems of hypertrophic scar repair.

Details
Condition Scar
Age 80 years and younger
Treatment Tissue-engineered skin grafts of autologous scar dermal scaffolds
Clinical Study IdentifierNCT04389164
SponsorFirst Affiliated Hospital, Sun Yat-Sen University
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

The patient is diagnosed as hypertrophic scar and needs surgical repair; The
scar size was 10cm2 to 200cm2, and the site was not limited; Patients with
stable vital signs and tolerable operation indicated by routine examination
Patients in good mental state, can follow the doctor's advice, regular return
Those whom the researchers considered unsuitable for inclusion; Patients have
participated in this study at any time in the past; Those whom the researchers
considered unsuitable for inclusion; Patients have participated in this study
at any time in the past

Exclusion Criteria

Those who did not meet the inclusion criteria were found after the selected
subjects; The follow-up time after inclusion was less than 2 times, and the
objective efficacy could not be evaluated (but the adverse reactions could be
evaluated); Subjects who violate protocol requirements
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.